Skip to content

ENdoscopIc Sleeve Gastroplasty Efficacy (ENvISaGE) Study in Obese Adults.

Weight loss efficacy, safety, and effect on comorbidity risk factors and quality of life of obese adults receiving Endoscopic Sleeve Gastroplasty (ESG) or Laparoscopic Sleeve Gastrectomy (LSG)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12618000337279
Acronym
ENvISaGE Study
Enrollment
82
Registered
2018-03-06
Start date
2018-06-26
Completion date
2019-05-17
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A new type of procedure for managing obesity has recently become available in Australia: Endoscopic Sleeve Gastroplasty (ESG), which stimulates weight loss by reducing gastric volume. Unlike the widely implemented laparoscopic sleeve gastrectomy (LSG), the less invasive and incisionless ESG is performed endoscopically and trans-orally. Therefore, the ESG will reduce surgery-related complications and recovery time. Therefore, a non-inferiority prospective cohort study will be undertaken to determine the weight loss efficacy, safety, and effect on comorbidity risk factors and quality of life of obese adults receiving Endoscopic Sleeve Gastroplasty (ESG) compared with Laparoscopic Sleeve Gastrectomy (LSG). 106 participants will be consecutively recruited from Weight Loss Solutions Australia on the Gold Coast. The primary outcome will be excess weight loss at 6-months post-procedure, and secondary outcomes will examine body composition (via DXA), quality of life, complications related to the procedure, lipid profile, blood pressure, comorbidities, blood pressure, and allied health use.

Interventions

After consultation with their proceduralist (gastroenterologist or surgeon), participants will select to undergo the ESG or the LSG. The ESG will be performed as per standard practice by one of the Weight Loss Solutions Australia (WLSA) surgeons. Patients are placed under general anesthesia for the procedure. After measurement of the gastric volume via aesophagogastroduodenoscopy, anterior and posterior suture placement sites are mapped. A cap-based flexible endoscopic suturing system (OverStit

After consultation with their proceduralist (gastroenterologist or surgeon), participants will select to undergo the ESG or the LSG. The ESG will be performed as per standard practice by one of the Weight Loss Solutions Australia (WLSA) surgeons. Patients are placed under general anesthesia for the procedure. After measurement of the gastric volume via aesophagogastroduodenoscopy, anterior and posterior suture placement sites are mapped. A cap-based flexible endoscopic suturing system (OverStitch; Apollo Endosurgery, Austin, TX) is used to perform the procedure. The ESG is created by invaginating the greater curvature of the stomach for formation of the sleeve. The final result is a tubular reconficuration of the gastric lumen. The Laparoscopic Sleeve Gastrectomy (LSG) will be peformed as per standard practice by one of the Weight Loss Solutions Australia (WLSA) surgeons. Patients are placed under general anesthesia for the procedure and local anesthetic is administered at all local trocar entrance sites. The abdominal cavity is accessed via a supraumbilical incision and using a trocar. Two staplers are used commencing at the pylorus up to the incisura angularis. The staple-line is inverted resulting in a gastric sleeve. The patients will be followed from baseline to six-months post-procedure.

Sponsors

Bond University
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Plan for ESG or LSG procedure. Aged 18 years or older. Able to provide written informed consent.

Exclusion criteria

Patient reported expected unavailability for face-to-face appointment at 6- and/or 12-months post-procedure.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 19, 2026